The human TEL gene is involved in several 12p13 chromosomal abnormalities present in various human hematological malignancies, the most frequent being the t(12;21)(p13;q22), speci®c for childhood acute lymphoblastic leukemia. The predicted product of TEL harbours an amino acid region similar to the ETS DNA binding domain. We now report the isolation of the murine TEL cDNA and the characterization of the human TEL proteins. Human and murine TEL proteins are particularly homologous within their aminoterminal regions and their ETS domains. TEL proteins are nuclear and display speci®c DNA binding activity toward classical ETS binding sites. In addition, we show that TEL mRNAs initiate translation at either of the two ®rst inframe ATGs (codon 1 and 43) to encode 50 kDa and 57 kDa TEL proteins. In vivo, each of these primary translational products is modi®ed by multiple phosphorylation events.
Introduction
In eukaryotic cells, transcriptional regulators are organized in families of genes characterized by their DNA binding domains. Members of the ETS family share a 85 amino acid region of homology, the ETS domain, responsible for nuclear localisation and sequence speci®c DNA-binding activity. ETS proteins bind to a GGAA/T core motif¯anked by 5 ± 8 nucleotides of surrounding sequences that contribute the speci®city of individual family members. Transcriptional activation domains have been identi®ed in several ETS proteins, and transcriptional activation by ETS proteins usually involves interaction with other transcription factors to achieve ®ne transcriptional regulation and/or target gene speci®city (Wasylyk et al., 1993; Ghysdael, 1995) .
The majority of chromosomal abnormalities observed in human malignancies involves genes coding for transcriptional factors (Rabbitts, 1994) . To date, several ETS domain encoding genes have been involved in chromosomal translocations.
The ®rst example characterized in human malignancies, is the fusion between the FLI1 and the EWS genes following the t(11;22)(q23;q12) in Ewing's sarcomas and peripheral neuroepitheliomas (Delattre et al., 1992) . Less frequent variant translocations recombine the EWS gene with the ERG gene, following the t(21;22)(q22;q12) (Zucman et al., 1993; Sorensen et al., 1994) or with ETV1 locus, following the t(7;22)(p22;q12) (Jeon et al., 1995) . As a result, a strong transactivation motif, contributed by EWS, is fused to the ETS DNA binding domain of FLI1, ERG or ETV1 (May et al., 1993; Bailly et al., 1994) . A similar mechanism appears to be involved for the TLS-ERG fused product that results from the t(16;21)(p11;q22) present in some human myeloid malignancies (Ichikawa et al., 1994) .
The TEL gene has been isolated by virtue of its recombination with the gene encoding the b chain of the platelet derived growth factor receptor (PDGFRb), following the t(5;12)(q33;p13) of chronic myelomonocytic leukemia (Golub et al., 1994) . In addition to its C terminal ETS domain, TEL possesses at its amino termini, a region of homology with several other ETS family members, that has been referred to as the B domain (Boulukos et al., 1989) and has been predicted to fold as a helix ± loop ± helix structure (Seth and Papas, 1990 ). It will here be referred to as NCR, for NH 2 terminal conserved region. The TEL gene has recently been shown to be involved in several 12p abnormalities in various hematopoietic malignancies and the emerging picture seems quite complex (Bernard et al., 1996) .
Following the t(12;22)(p13;q11) observed in some myeloid proliferations, the TEL gene is fused to the MN1 gene, a putative transcription factor encoding gene . This situation is potentially similar to the EWS-FLI1 gene fusion, since the crucial chimeric protein, MN1-TEL, includes the ETS domain of TEL.
As a result of both the t(5;12) and t(9;12), the NH 2 part of TEL, containing the NCR, is fused to the protein kinase domain of PDGFRb and ABL, respectively (Golub et al., 1994; Papadopoulos et al., 1995) . The fusion proteins exhibit a constitutive kinase activity that depends on the presence of the NCR of TEL (C Jousset, CO, OAB and JG, unpublished results) .
Following the t(12;21)(p13;q22), frequently observed in childhood B lineage acute lymphoblastic leukemia (ALL), the 336 ®rst amino acids of TEL are fused to most of the aminoacid sequence of AML1, one of the DNA binding subunit of the core binding factor (CBF) Meyers and Hiebert, 1995; Romana et al., 1995a,b; Shurtle et al., 1995; McLean et al., 1996; Raynaud et al., 1996) .
In addition, because of the loss of heterozygosity observed in childhood ALL samples within a chromosome 12 region that encompasses the TEL locus, a tumor suppressor status has also been proposed for TEL (CaveÂ et al., 1995; Sato et al., 1995; Stegmaier et al., 1995) . Deletion of the TEL gene has, in fact been shown to be frequently associated with t(12;21) in this subtype of leukemias Romana et al., 1995a,b; Raynaud et al., 1996) , suggesting that the deletion of the TEL locus would be meaningful only in the context of the t(12;21).
In a ®rst step to gain insight toward the functional properties of the TEL proteins, we isolated a murine TEL cDNA and compared the murine and human TEL proteins. In addition, we characterize human TEL protein isoforms and post transcriptional modi®cations in vivo and established their DNA binding capacities.
Results
Cloning of murine TEL cDNA ETS proteins are conserved among mammalian species. To isolate a mouse TEL cDNA, we selected two oligonucleotides (F3 and B9), based on the human TEL cDNA sequence, located within two potentially highly conserved region of TEL, one upstream of the sequences coding for the NCR (F3), and the other in the sequences coding for the ETS domain (B9). Using these primers, a 1 kb fragment was ampli®ed by RT ± PCR using RNA from the murine cell line WEHI 3. This fragment was used as a probe to screen a spleen cDNA library.
The largest insert (3.5 kb) recovered from the two isolated clones was sequenced (Figure 1 ). Amino acid translation revealed a large open reading frame (ORF), limited by stop codons and preceded by 1230 bp of noncoding sequences. The predicted protein is a 485 amino acids (AA) protein highly homologous to the human TEL protein particularly in the NCR and the ETS domain. The predicted murine TEL protein possesses a 37 AA C terminal extention, with respect to the human TEL product.
Partial nucleotide sequence analysis of the second cDNA clone indicated that it partially overlapped with the ®rst one but diered at the 3' end, downstream of the TEL ORF, presumably due to alternative splicing. These two cDNAs therefore possess the same coding capacity regarding the COOH end of TEL.
Chromosomal localization of the murine TEL gene was performed on normal metaphase murine chromosomes by¯uorescent in situ hybridization (FISH). The gene was located on chromosome 6 band G2, a region syntenic to human chromosome 12p12-p13 (data not shown).
The nucleotide sequences surrounding the ®rst three in-frame ATGs are 100% conserved between human and mouse. Notably, the second ATG (M43) is in a more favorable context for translation initiation than the ®rst one (Kozak, 1986) and is used as an alternate ATG. We previously isolated variant cDNAs, presumably originating from alternative splicing and/or transcriptional initiation, from a RAJI cDNA library (Romana et al., 1995a) , and one of them suggested transcriptional initiation at the third ATG (M89). In order to identify such alternatively spliced RNAs, anchored PCR experiments were performed starting from mouse spleen RNA. No RNA species similar to those isolated in human (SR12, see Romana et al., 1995a) could, however, be isolated (data not shown).
Western blotting detection of TEL proteins
In order to identify TEL in vivo, a rabbit antiserum was raised against the C terminal part of the TEL protein (the ETS domain of TEL; AA 338 to 452). The antiserum (antiCTEL) was demonstrated to immunoprecipitate TEL from Cos cells transiently transfected with a TEL expression vector but not with empty vector (data not shown).
To detect endogenous TEL proteins, immunoblotting analyses were performed using the anti CTEL antibodies or the preimmune serum as control (Figure 2) . The human malignant cell line RAJI was chosen because it has been shown to express normal TEL RNA (Romana et al., 1995a) . In total cellular extracts, two broad signals were detected with the antiCTEL immuneserum but not with preimmune serum (Figure 2a, left panel) . Both signals disappeared when the antiCTEL serum was blocked with an excess of the GST-COOH protein, used as an immunogen, but not following preincubation of the serum with a GST fusion protein containing the NH 2 part of the TEL protein (GST-NH 2 ). As described below each band corresponds to translational initiation at the ®rst or the second in-frame ATGs present in the TEL mRNA.
Similar results were obtained using extracts from the WEHI 3 murine cell line, the murine TEL proteins displaying, as expected from sequence analysis of the Western blotting analysis of TEL expression in human malignant cell lines Previous studies by Northern blot analysis showed presence of the TEL mRNA in all organs tested (Golub et al., 1994) . To study the expression of TEL at the protein level, a series of human cell lines, the majority of them representing dierent lineages and maturation stages of hematopoietic dierentiation, were analysed by Western blot analysis using the antiCTEL immuneserum ( Figure 2b ). When electrophoresis was performed using long gels, the human TEL products were resolved as doublets of apparent molecular weight of 57 and 60 kDa for the slower migrating species, and of 50 and 52 kDa for the faster Figure 2 Western blotting analysis of endogenous TEL proteins. (a) Validation of rabbit anti CTEL immuneserum for analysis of total cellular extracts by Western blotting. Two proteins species were immunodetected in cellular extracts of a human malignant cell line (RAJI) with an antiCTEL serum but not with preimmune rabbit serum (PI). These bands are fully competed by preincubation of antiCTEL with the GST-COOH fusion protein used for immunization, but not with an unrelated GST fusion protein (GST-NH 2 ). Position of molecular weight markers are shown at the left of the picture. Identical results were observed upon analysis of a murine malignant cell line WEHI 3, the murine TEL proteins migrating slightly slower. A nonspeci®c band, not competed by the GST-COOH protein, is detected between the murine TEL proteins. Direct Western blotting comparison between human and murine TEL is shown at the right side of the ®gure. (b) TEL expression in human malignant cell lines. Western blotting analysis of total cellular extracts, using antiCTEL immunesera, detected the two doublet corresponding to the TEL protein in the majority of the cell lines tested. Some of them (Molt3, Molt4, U266, SKW3 for example) express low level of TEL. Some samples were loaded several times for comparison purposes or as negative control (Reh). TEL protein species are shown by arrows. Note that a nonTEL band is migrating slightly faster than TEL species in U266 samples migrating one. Expression of the TEL proteins was found to be widely variable, ranging from high level (see CCRF-CEM, for example) to low level (see Molt 3, for example). Using Northern blotting analysis, the Molt 4 cell line was found to express a detectable level of normally sized TEL transcript, suggesting that TEL protein could be present but expressed below our threshold of detection.
The ratio between the two TEL species (57 ± 60 kDa and 50 ± 52 kDa) showed little variation, the majority of the cell lines tested expressing more of the 57 ± 60 kDa than of the 50 ± 52 kDa species. The RPMI 8402 cell line represents therefore an exception, since it possesses more of the 50 ± 52 kDa than of the 57 ± 60 kDa species. No obvious relation between TEL expression and lineage or state of dierentiation of the malignant cell lines was observed.
A human malignant cell line with a t(12;21)(p13;q22)
Using our anti CTEL antiserum, Reh, a B lymphoblastic leukemic cell line (Rosenfeld et al., 1977; Venaut et al., 1981) , did not show any expression of TEL. Analysis of metaphase chromosomes of this cell line was performed both by banding and FISH techniques and demonstrated a chromosomal abnormality affecting the two 12p12-13 regions. One chromosome 12 was shown by FISH to harbor a t(12;21) translocation, in keeping with RT ± PCR and Southern blotting analysis of nucleic acids extracted from this cell line (data not shown). The other chromosome 12 shows a t(5;12) but TEL-PDGFRb recombination could not be demonstrated, neither by FISH nor by Southern blotting nor RT ± PCR experiments (data not shown). On the opposite, this allele of TEL appears deleted as judged from Southern blotting analysis. To summarize our results, the karyotype of Reh can be written as follows: 46,X,del(3)(p21),del(4) (q31),t(5;12) (q31;p13),der (12)t (4;12)(q31;q24)add(12)(p13),der(16)t (16;21)(q23;q22)x2, der(21)t(12;21)(p13;q22) and the cell line expresses a TEL-AML1 fusion transcript but neither AML1-TEL nor normal TEL transcript (data not shown). Therefore, this cell line was used as a negative control for expression of the epitopes of the C terminal part of TEL in our experiments.
Subcellular localization of the TEL proteins
Since they possess an ETS DNA binding domain, the TEL proteins are expected to localize in the cell nucleus, and this localization could be subject to regulatory events. To investigate this point, the antiCTEL was used in immuno¯uorescence experiments on ®xed RAJI cells (Figure 3) . A strong, speckled FITC¯uorescence, appearing in yellow following electronic processing, was observed, when the immuneserum was used directly or after incubation with an unrelevant GST fusion protein (GST-NH 2 ) (Figure 3a and b) . The¯uorescence signal localizes within the nucleus of the cells as it overlaps with the DAPI signal (which stains DNA), appearing in red following electronic processing. The yellow¯uorescent signal was completely abrogated when antiCTEL was preincubated with the GST-COOH protein (Figure 3c ) or when the FITC labeled second antibodies were used directly (without antiCTEL antibodies; data not shown). Similarly, Reh cells which do not express normal TEL protein failed to show nuclear fluorescence with antiCTEL immuneserum (Figure 3d ).
Analysis of TEL protein diversity
With the exception of one cDNA (SR12; Romana et al., 1995a) , all the human TEL cDNAs analysed to date show the same coding capacity. The detection of several proteins by our anti TEL antibody (Figure 2 ) could therefore re¯ect either detection of a TEL-related antigen, or extensive post translational modi®cation of bona ®de TEL, or a variation in translational initiation. To address these questions, human and murine TEL cDNAs were in vitro translated (IVT). Both cDNAs directed the synthesis of two protein species of estimated molecular weight of 50 kDa and 57 kDa for human TEL and of 53 kDa and 60 kDa for murine TEL (Figure 4a ). The murine TEL proteins are larger than human TEL, in keeping with prediction from the analysis of the corresponding cDNAs ( Figure 1 ) and with Western blotting analysis of cellular TEL products (Figure 2) . Synthesis of two protein species, from both the murine or human cDNAs, suggested variation in translational initiation.
To con®rm this hypothesis, we constructed eukaryotic expression vectors directing expression of a human full length TEL product (FLTEL), a human TEL protein initiated at the second in-frame methionine (codon 43; M43TEL), and a human TEL protein initiated at the third in-frame ATG (codon 89; M89TEL).
To compare the relative migration of in vitro and in vivo synthesized TEL, cellular extracts from transiently transfected Cos cells were loaded next to cellular extracts and to in vitro translated human TEL, and immunoblotted using antiCTEL (Figure 4b) . In vitro synthesized human TEL proteins comigrated with the faster TEL species detected in Cos cells (i.e. 50 and 57 kDa), suggesting that the slower migrating species could be due to post translational modi®cations.
The proteins detected in Cos cells transfected with M43TEL migrated similarly to the faster species detected in cellular extracts and in IVT of full length TEL cDNA. This indicated that the fastest TEL migrating species corresponds to a protein translated starting from second in-frame ATG (codon 43).
In addition to the 50 kDa species corresponding to translational initiation at codon 43, Cos cells transfected with FLTEL express larger protein species, likely to all derive from translational initiation at the ®rst in-frame ATG. The corresponding broad signal is resolved in several bands upon shorter exposure times. As shown below, this heterogeneity corresponds to extensive modi®cation of M1 TEL by phosphorylation. No endogenous TEL protein was detected at the size corresponding to the M89 TEL product.
We concluded that translation of TEL mRNAs can occur at either ®rst or second in-frame ATG, directing the synthesis of 50 and 57 kDa species.
Phosphorylation of TEL proteins
Several ETS family proteins are known to be phosphorylated and these modi®cations have been shown to play an essential role in modulating their activity (Marais et al., 1993; Pongubala et al., 1993; Rabault and Ghysdael, 1994; Rabault et al., 1996; Yang, 1996) . In order to investigate the phosphoryla- Treatment of a TEL immunoprecipitate of Cos cells transfected with FLTEL with acid phosphatase resulted in the disappearance of the 60 kDa species and a slight increase in the electrophoretic mobility of the 57 kDa species (Figure 5 , left lane). These eects are speci®c because they are not observed following similar treatment in the presence of phosphatase inhibitors. Following phosphatase treatment, proteins encoded by M43TEL showed a similar increase in their electrophoretic mobility to that observed for the 57 kDa species encoded by FLTEL ( Figure 5 ).
We therefore conclude that TEL proteins are phosphorylated in transfected Cos cells and that the 60 kDa species represent an hyperphosphorylated form of TEL.
TEL is a sequence-speci®c DNA binding protein
To analyse whether TEL is endowed with speci®c DNA binding properties, whole cell extracts of Sf9 insect cells infected with a recombinant baculovirus directing the expression of TEL were used in electrophoretic mobility shift assays using as radioactive probe an ETS binding site (EBS) oligonucleotide which we previously showed to bind a variety of ETS proteins (oligonucleotide A; Bosselut et al., 1993) . Extracts of non infected Sf9 cells were used as control. As shown in Figure 6 , TEL-containing extracts generated a speci®c complex in these conditions (Figure 6a , compare lanes 1, 2 and 5). This complex represents binding of TEL to the oligonucleotide probe since it was speci®cally inhibited or supershifted by antisera against the C terminal part (antiCTEL) or the NH 2 terminal part of TEL, but not by a control antiserum (Figure 6a, compare lanes 5 ± 8) . This complex corresponds to speci®c binding of TEL to DNA since its formation was abolished by a 50-fold molar excess of unlabeled oligonucleotide A but not mutant oligonucleotide (oligonucleotide M) carrying a GG-to-CC transversion in the EBS core sequence (Figure 6b, compare lanes 1 ± 3) . Similar results were obtained using other EBS diering from oligonucleotide A in the sequences¯anking the GGAA core (data not shown). We conclude from these experiments that TEL is a sequence-speci®c DNA binding protein which recognizes classical EBS.
Discussion
The TEL gene is located on the short arm of human chromosome 12, on band 12p13, and is involved in several recurrent chromosomal translocations observed in various human hematopoietic malignancies. The predicted TEL product belongs to a subset of ETS proteins that share a conserved region at their NH 2 terminal domain. The crucial chimeric proteins produced as a result of those chromosomal translocations contain the NH 2 moiety of TEL fused either to a tyrosine kinase domain, contributed by ABL or PDGFRb proteins (Golub et al., 1994; Papadopoulos et al., 1995) , or to a DNA-binding subunit of a known transcriptional factor, AML1 Romana et al., 1995a) . In contrast, the ETS domain of TEL is fused to a protein of unknown function, MN1, following the t(12;22) . In addition, deletions of the TEL locus have been frequently observed, which appear to be associated with t(12;21) (CaveÂ et al., 1995; Golub et al., 1995; Raynaud et al., 1996; Romana et al., 1995a,b; Sato et al., 1995; Stegmaier et al., 1995) . These observations prompted us to compare the murine and the human TEL sequences and to identify and characterize the TEL proteins. Nucleotide sequence analysis of a murine TEL cDNA predicted a larger TEL product in mouse (485 AA) than in human (452 AA), with a high similarity between the two species. As expected, the identity between the two proteins is particularly high within the NCR (97%) and the ETS domain (100%). The identity is lower in the central part of the protein and, since transcriptional regulatory domains are known to be weakly conserved between species, this region might be responsible for the transcriptional regulation by TEL, similarly to other ETS proteins members (Wasylyk et al., 1993) . The murine TEL protein possesses a 37 AA C terminal extension with respect to human TEL. The C terminal part of TEL is acidic both in human and murine TEL proteins and could possess transcriptional regulation properties.
Alignment of the ETS domain of human TEL with consensus ETS domain sequences shows several speci®c features that are conserved in murine TEL.
The tripeptide FLL/V (AA 340 to 342 of human ETS1), seen in all ETS proteins is changed to YVY (AA 344 to 346 of human TEL). The triplet YYY (AA 395 to 397 of human ETS1), present in all ETS proteins except SPI 1, is HYY (AA 400 to 402 of human TEL). Both changes are present in murine TEL protein. These changes do not prevent TEL from binding EBS in vitro, since our electrophoretic mobility shift assays show that human TEL protein binds classical ETS binding sites.
Transactivation properties of the TEL proteins were investigated using CAT assays. We could not see any eect of TEL expression on transcriptional activity using reporter genes under the control of several EBS containing sites promoters in Hela cells (data not shown). These observations are in keeping with published results demonstrating a dominant negative eect of the TELAML1 fusion product with respect to transcriptional activation by AML1 (Hiebert et al., 1996) . Other explanations, such as the lack of cofactors or signal speci®c post-transcriptional modi®cations in our experiments could also be responsible for the absence of transcriptional activation as described for other ETS proteins (Marais et al., 1993; Giovane et al., 1994) .
To characterize the endogenous TEL proteins, a rabbit antiserum was raised against the C terminal part of TEL. By Western blotting analysis, two forms of TEL were detected both in human and murine cell lines. Each of these forms resolved as doublets.
Our data obtained using transiently transfected Cos cells show that both variation at translational initiation site and phosphorylation participate to the complex pattern displayed by the overexpressed TEL proteins and by the endogenous TEL proteins. Activation of the Ras signalling pathway has been demonstrated to lead to phosphorylation of the mammalian Elk1, SAP1a, SAP2, ETS1, ETS2 and ETV1/ER81, and drosophila YAN and POINTED proteins (Janknecht et al., 1993 (Janknecht et al., , 1995 Marais et al., 1993; Brunner et al., 1994; Price et al., 1995; Rebay and Rubin, 1995) . Although TEL contains several putative consensus phosphorylation sites for MAP kinase which are conserved in murine TEL, it is not yet known if TEL is a target of these protein kinases. Phosphorylation of several ETS family members has been demonstrated to regulate their transcriptional activity by aecting their DNA binding capacity (Rabault and Ghysdael, 1994) , their interaction with other proteins (Pongubala et al., 1993) , their transcriptional activation properties (Marais et al., 1993) .
TEL is more closely related to YAN than to other members of the ETS subfamily. Ras dependent phosphorylation has been proposed to regulate the sub cellular localization of YAN (Rebay and Rubin, 1995) . Our immuno¯uorescence studies show that TEL proteins are located in the nucleus of several human malignant cells (Figure 3 and data not shown) . Therefore, our data do not support regulation of TEL subcellular localisation by phosphorylation.
The full length TEL protein species initiated at codon 1 is usually expressed at higher level than the M43TEL (Figure 2b and data not shown). Interestingly, the full length TEL protein possesses a putative MAPK site (AA 20 ± 23) , that is absent in M43TEL. Furthermore, the NCR of TEL is an oligomerisation domain, indicating that M1 TEL and M43TEL exist as either homo or heterodimers. Experiments are in progress to determine if these forms have similar functions and if they are similarly regulated.
Materials and methods

Cell lines
Human cell lines have been widely described. Most of them were established from hematological malignant samples. RS411, OB5, 380, PBEI, 697, Nalm 6, Jea, Reh (ATCC CRL 8286): B lineage ALL RAJI: Burkitt lymphoma; U266: Mature B cell malignancy; CCRF-CEM, Molt 4, Molt 3, KE37, SKW3, CCRF-HSB2, Rex, RPMI 8402; T ALL Sup T1, HUT 78: Mature T cell malignancies; HEL, HL60, U937: Myeloid malignancies; Hela: cervical malignancy; WEHI 3 is a murine promyelocytic cell line.
Nucleic acid methods
Random-primed cDNA, synthesized from a murine cell line RNA (WEHI 3), was submitted to PCR ampli®cation as previously described (Romana et al., 1995b) . TEL primers were F3 (nt 148 ± 169: AGGATG GAGGAAGACTCGATCC) and B9 (nt 1171 ± 1151: GGTTTCCCCACAGTCGAGCCA). Numbering is according to (Golub et al., 1994) .
The cDNA library was established from 5 mg of poly(A) + RNA, extracted from the spleen of a C57Black/6J mouse, using a cDNA synthesis kit. The double strand cDNA was ligated to lambda ZapII EcoRI phage arms with EcoRI ± NotI adapators. The library was screened using standard protocols (Sambrook et al., 1989) . The ORF of the murine TEL cDNA was subcloned into pBKS (Stratagene, La Jolla, CA) vector using the EcoRI restriction site present in the 5' untranslated region of the cDNA. The cDNA encoding the C terminal part of human TEL (AA 338 to 452) was introduced into pGEX2T vector using PCR ampli®cation, using primer (GTAGATCTTGTA-GACTGCTTTGGGA). The 3' primer (TCAAGCTTCT-GAGGTGGACTGTTGGTT) was the same in each PCR mediated subcloning.
The cDNA encoding the NH 2 part of human TEL (AA 2 to 267) was PCR ampli®ed using TAAGATCTGA-GACTCCTGCTCAGT as a 5' primer, and subcloned into PGEX2T vector using a PvuII restriction enzyme site present in human TEL cDNA as a 3' cloning site.
The SV40 promoter-based expression vector DEB has been described elsewhere (Rabault and Ghysdael, 1994) . Inserts were Phosphoproteins encoded by the TEL gene H Poirel et al cloned in-frame with the HA epitope encoding sequences using PCR techniques starting from human TEL cDNA and checked by sequence analysis. Oligonucleotides were (TAAGATCTA-CATGTCTGAGACTCCTGC) for the full length TEL (DEB TEL FLTEL) and (TAAGATCTGCAAAGCTCTCCT) for TEL starting at the third methionine (DEB TEL M89). The vector expressing TEL starting at M43 was obtained from DEB full length TEL after EcoRI+XhoI digestion and recircularisation (DEB TEL M43). This latter construct has lost the HA epitope encoding sequences.
Plasmids were in vitro transcribed/translated using the TNT kit (Promega, Madison, WI), the positive control was provided in the kit and the negative control was no template. Nucleotide sequence analysis was performed using the T7 sequencing kit (Pharmacia, Les Ulis, France).
Human TEL ORF was PCR ampli®ed using 5' oligonucleotide (TAAGATCTCTGCTCAGTGTAGCAT-TAAG) and 3' as for the other PCR mediated subcloning, subcloned into DEB, and checked by nucleotide sequencing. A 5' EcoRI ± 3' blunted HindIII site fragment was subcloned into PVL13 92. The corresponding virus was rescued using a Pharmingen kit following the manufacturer's instructions.
PCR and Southern blotting analysis were performed using previously described reagents (Romana et al., 1995b) . FISH probes generated in our laboratory, (chromosomes 16 and 21 paints), or purchased [chromosome 5 and 12 paints from Biosys (Compeigne, France) and Chromosome 12 alphoid probe (Gaithesburg, MD, USA)], or as previously described (Romana et al., 1995b) .
DNA binding studies
Preparation of whole cell extracts of infected Sf9 cells as well as the condition for electrophoretic mobility shift assays were as described previously (Bosselut et al., 1990) . The EBS used as a probe or competitor (oligonucleotide A) has the sequence ATAAACAGGAAGTGG¯anked by an AvaI restriction enzyme site to allow radioactive labelling with the Klenow fragment of DNA polymerase I in the presence of a [ 32 P]dCTP. The mutant oligonucleotide M has the sequence ATAAACACCAAGTGG.
Polyclonal antibodies
The GST fusion proteins were puri®ed from the soluble fraction of bacterial lysates following the manufacturer's instructions (Pharmacia, Les Ulis, France). Rabbits were injected with 500 mg of GST-COOH protein or GST-NH 2 protein, in 1 ml of complete Freund adjuvant. Subsequent injections were made monthly with 250 mg of protein in 1 ml of incomplete Freund adjuvant.
Immunoblotting
Cells were washed once in PBS and lysed in Laemmli buer (15 ml/10 6 cells). After 3' boiling, 15 to 30 ml, depending on the size of the gel, were loaded on 8 or 10% SDS-polyacrylamide gels and blotted onto nitrocellulose ®lters. The quality of the transfer onto the membrane was attested with Ponceau red coloration. The ®lters were then probed with a 1 : 1000 dilution of rabbit antisera in TBST (20 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5% Tween) 5% dry milk, and revealed by enhanced chemiluminescence, following the manufacturer's instructions (Amersham, Les Ulis, France). Note that B-EBV, Jea, SupT1, Rex and 380 samples were underloaded, with respect to the Ponceau red coloration.
Immuno¯uorescence studies
Cells were cytocentrifuged on microscope slides, ®xed with 3% paraformaldehyde in phosphate buered saline (PBS) for 10 min and washed three times in PBS and incubated in 20 mM Glycine in PBS. Cells were then permeabilized with 0.1% Triton X-100 in PBS and incubated with a 1/200 dilution of immuneserum in the same buer as for Western blotting (TBST 5% dry milk) for 60 min. After three washes,¯uorescein (FITC) labeled second antibody (Donkey anti rabbit, Amersham, les Ulis, France) was incubated for 20 min and washed following the instructions of the manufacturer.
Microscopy analysis was carried out with a MRC 1000 (Bio-Rad, Henel, Hempstead, UK) scanning confocal laser microscopy system equipped with krypton-argon ion and u.v. lasers (488/568 nm and 363 nm respectively), and dual ®lters for¯uorescein and DAPI emissions. The images were derived through electronic processing methods, which enhance the positive reaction signals by a combination of contrast normalization and scaling adjustments, using the Cosmos software package (Bio-Rad, Henel, Hempstead, UK). Parfocal graphic ®le from Guy Cox software. Due to electronic processing,¯uorescein and DAPI emissions appear in yellow and red, respectively.
Immunoprecipitation
Five 10
5 Cos 1 cells were transfected with expression vector using the phosphate calcium method. After 48 h, cells were metabolically labeled for 90 min with [
35 S]Easytag (DuPont) and lysed in 2 ml of RIPA buer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% Sodium desoxycholate, 0.1% Sodium Dodecyl Sulfate) with protease (1% aprotinin, 100 mg/ml phenylmethylsulfonyl uoride, 10 mg/ml leupeptin) and phosphatase (20 mM b glycerophosphate, 50 mM OrthoVanadate, 10 mM NaF) inhibitors. After incubation (60 min at 48C) of 0.3 ml lysed cells with 1 to 4 ml serum, the immunocomplexes were isolated with protein A Sepharose (Pharmacia, Les Ulis, France). Samples were diluted in Laemmli buer and loaded on denaturing acrylamids gels.
Phosphorylation studies
Immunoprecipitates were treated with acid phosphatase (Sygma) for 30 min at 378C in 10 mM PIPES pH 6, with or without phosphatase inhibitors, and analysed on denaturing acrylamide gels.
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